Yamashita Satoshi, Furumoto Kayo, Nobukiyo Asako, Kamohara Masashi, Ushijima Toshikazu, Furukawa Toshinori
Carcinogenesis Division, National Cancer Center Research Institute, Tokyo, Japan.
Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3153-9.
The Upjohn Pharmaceuticals Limited (UPL) rat is a unique model for cataracts, which are inherited as an autosomal semidominant trait and expressed as early-onset (E-type) cataracts in homozygotes and as late-onset (L-type) cataracts in heterozygotes. In this study, a gene and its modifier, which are responsible for formation of cataract, were mapped.
Fifty-five BN x (BN x UPL)F(1) backcross rats and 133 BN x UPL intercross rats were produced. The cataracts present in the rats at eye opening were diagnosed as E-type. Cataracts that developed after eye opening were diagnosed as L-type, and the ages when complete opacity in the lens was observed were used as a quantitative trait to map a gene that modifies the development of mature cataracts. Linkage analysis was performed using 64 arbitrarily primed-representational difference analysis (AP-RDA) markers and 74 microsatellite markers.
A gene responsible for the formation of cataract was mapped to the vicinity of D2Rat134 on rat chromosome (chr) 2. A candidate gene, connexin 50 (Cx50/Gja8), had a C-to-T transition at codon 340 that is predicted to result in a nonconservative substitution of arginine by tryptophan. Recombination in the Cx50 genotype and formation of cataract was not observed. By quantitative trait loci analysis, a gene that modified the age of the development of mature cataract was mapped on rat chr 5.
A candidate gene for formation of cataracts in UPL rats was mapped to rat chr 2, and the Cx50 gene was a strong candidate. In addition, a potential modifier gene was mapped on chr 5. Future cloning of these genes will provide good targets for new therapies that can delay the progression of cataracts.
Upjohn制药有限公司(UPL)大鼠是一种独特的白内障模型,白内障以常染色体半显性性状遗传,在纯合子中表现为早发性(E型)白内障,在杂合子中表现为迟发性(L型)白内障。在本研究中,对负责白内障形成的一个基因及其修饰基因进行了定位。
培育了55只BN×(BN×UPL)F1回交大鼠和133只BN×UPL杂交大鼠。睁眼时大鼠出现的白内障被诊断为E型。睁眼后出现的白内障被诊断为L型,将观察到晶状体完全混浊的年龄作为一个数量性状来定位修饰成熟白内障发育的基因。使用64个任意引物代表性差异分析(AP-RDA)标记和74个微卫星标记进行连锁分析。
一个负责白内障形成的基因被定位到大鼠2号染色体(chr)上D2Rat134附近。一个候选基因,连接蛋白50(Cx50/Gja8),在第340密码子处发生了C到T的转换,预计会导致精氨酸被色氨酸非保守性替代。未观察到Cx50基因型的重组和白内障的形成。通过数量性状位点分析发现,一个修饰成熟白内障发育年龄的基因被定位到大鼠5号染色体上。
UPL大鼠白内障形成的一个候选基因被定位到大鼠2号染色体上,Cx50基因是一个有力的候选基因。此外,一个潜在的修饰基因被定位到5号染色体上。这些基因的未来克隆将为延缓白内障进展的新疗法提供良好的靶点。